Caris Life Sciences, Inc. is 4.1x more valuable than CareDx, Inc. by market capitalization ($4.93 B vs $1.21 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | CDNA | CAI |
|---|---|---|
| Market cap | $1.21 B | $4.93 B |
| US-listed rank | #2498 | #1401 |
| Revenue (latest FY) | $379.81M | $812.03M |
| Net income (latest FY) | -$21.35M | -$68.09M |
| Net margin | -5.6% | -8.4% |
| SEC filings | 1,336 | 102 |
Caris Life Sciences, Inc. is 4.1x more valuable than CareDx, Inc. by market capitalization ($4.93 B vs $1.21 B).
In their latest fiscal years, CareDx, Inc. reported $379.81M in revenue while Caris Life Sciences, Inc. reported $812.03M.
Full pages: CareDx, Inc. and Caris Life Sciences, Inc., or browse the full rankings.